Drug Discovery Informatics Market
Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) Forecast Period, (2026-2035)
Industry Overview
Drug discovery informatics market was valued at $3,525.7 million in 2025 and is projected to reach $7,682.1 million by 2035, growing at a CAGR of 8.2% during the forecast period (2026-2035). The Global Drug Discovery Informatics Market is advancing as pharmaceutical and biotechnology companies intensify their focus on precision-driven R&D and data-centric decision frameworks. Growth is being reinforced by the rising adoption of AI-enabled molecular modeling, high-throughput screening analytics, and cloud-based platforms that streamline early-stage discovery workflows. Demand is further supported by the increasing volume of complex biological datasets requiring specialized computational tools for target identification and validation. As regulatory agencies emphasize evidence-backed development processes, informatics solutions are becoming indispensable in reducing cycle times and improving prediction accuracy.
Market Dynamics
Increasing Adoption of Data-Driven Research Frameworks Across Life Sciences
Pharmaceutical and biotechnology organizations are steadily embedding advanced informatics tools into their discovery workflows to manage the growing volume and complexity of biological and chemical data. The industry’s shift toward precision-oriented research is prompting wider use of platforms that support target identification, molecular modeling, and predictive analytics. Companies are prioritizing solutions that enhance decision accuracy while reducing early-stage development timelines. As digital compliance expectations rise, demand for validated and interoperable informatics systems continues to strengthen. This transition toward data-centric R&D is becoming a central force influencing global market development.
Growing Integration of AI and Automation in Discovery Pipelines
AI-enabled algorithms and automated analytics are being adopted across drug discovery functions to streamline screening, accelerate hit-to-lead processes, and enhance modeling accuracy. Advances in machine learning, cloud computing, and high-throughput data processing are enabling teams to evaluate larger datasets with greater precision and speed. Technology providers are investing in platforms that offer scalable computational power and adaptable workflow tools suited for diverse therapeutic research areas. These innovations are helping organizations improve productivity without major changes to existing infrastructure. As a result, the expanding use of intelligent, automated informatics solutions is emerging as a key driver of global market growth.
Market Segmentation
- Based on the function, the market is segmented into docking, molecular modeling, libraries & database preparation, sequencing & target data analysis, and others.
- Based on the end-user, the market is segmented into pharmaceutical & biotechnology companies, contract research organizations, and others.
Docking Segment to Lead the Market with the Largest Share
The docking segment is emerging as the most influential component of the drug discovery informatics landscape, supported by its critical role in accelerating early-stage compound evaluation. Research teams increasingly rely on docking tools to efficiently screen vast chemical libraries and identify promising ligand–receptor interactions with a high degree of accuracy. This capability helps reduce experimental workloads and shortens the time required to advance viable candidates. Continuous enhancements in scoring algorithms, integration with AI-driven modelling, and improved visualization features are further strengthening docking’s position in modern discovery workflows. As pharmaceutical and biotechnology organizations intensify their focus on computational precision, the demand for robust docking platforms continues to anchor this segment’s dominant market share.
Pharmaceutical & Biotechnology Companies: A Key Segment in Market Growth
Pharmaceutical and biotechnology firms remain the primary drivers of demand in the drug discovery informatics market, owing to their sustained investments in advanced computational tools that enhance research efficiency. These organizations rely on informatics platforms to streamline target identification, optimize lead candidates, and reduce early-stage development risks. As pipelines expand to include biologics, gene therapies, and complex multimodal treatments, the need for integrated data analysis and predictive modeling becomes even more essential. Companies are also strengthening digital transformation initiatives, enabling smoother adoption of AI-supported discovery methods. Collectively, these factors reinforce the strong influence of pharmaceutical and biotechnology companies in shaping overall market momentum.
Regional Outlook
The global drug discovery informatics market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Strengthening Digital Research Ecosystem Across Europe
Europe is experiencing steady expansion in the drug discovery informatics market as research centers, pharmaceutical companies, and academic institutions elevate their use of advanced digital tools in early-stage development. Ongoing investments in data infrastructure and cross-border scientific collaboration are enabling smoother integration of computational platforms into discovery workflows. Regional initiatives supporting translational research are encouraging wider adoption of modeling, analytics, and cloud-based systems that enhance project efficiency. Technology providers are also tailoring solutions to align with Europe’s stringent data governance and research-quality standards, further increasing market acceptance. With growing emphasis on evidence-driven innovation, the region continues to build a strong foundation for informatics-led drug discovery.
North America Region Dominates the Market with Major Share
North America maintains a leading position in the drug discovery informatics Market as research institutions and biopharmaceutical companies continue to expand their investment in advanced computational tools. The region benefits from a well-established digital research infrastructure that supports efficient handling of large biological datasets. Increasing collaboration between technology developers and life-science organizations is further enhancing the adoption of specialized analytical platforms. Access to substantial funding for early-stage innovation allows research teams to integrate sophisticated modeling and data-analysis solutions into their workflows. Regulatory emphasis on structured, data-driven evaluation is also strengthening reliance on informatics across discovery programs. Together, these factors reinforce North America’s strong market presence.
Market Players Outlook
The major companies operating in the global drug discovery informatics market include Dassault Systèmes SE, Clarivate plc, Illumina, Inc, Schrödinger, Inc, Thermo Fisher Scientific Inc., among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In June 2025, BioAro launched its new platform, PanOmiQ Research, a unified “omics-to-therapeutics” ecosystem combining multi-omics data analysis with an AI-powered drug discovery module. This marks a significant step toward fully integrated computational solutions for early-stage target identification and drug candidate generation.
- In April 2025, Revvity, Inc. rolled out Signals One, a unified informatics platform designed to streamline data management and integration across the entire drug discovery lifecycle from assay data to in vivo analytics. The platform aims to reduce silos and enhance collaborative research workflows.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global drug discovery informatics market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Drug Discovery Informatics Market Sales Analysis – Function | End-User ($ Million)
- Drug Discovery Informatics Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Drug Discovery Informatics Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Drug Discovery Informatics Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Drug Discovery Informatics Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Drug Discovery Informatics Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Drug Discovery Informatics Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Drug Discovery Informatics Market Revenue and Share by Manufacturers
- Drug Discovery Informatics Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Dassault Systèmes SE
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Clarivate plc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Illumina, Inc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Schrödinger, Inc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Thermo Fisher Scientific Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Dassault Systèmes SE
- Key Company Analysis
- Global Drug Discovery Informatics Market Sales Analysis by Function ($ Million)
- Docking
- Molecular Modeling
- Libraries & Database Preparation
- Sequencing & Target Data Analysis
- Others
- Global Drug Discovery Informatics Market Sales Analysis by End-User ($ Million)
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Others
- Regional Analysis
- North American Drug Discovery Informatics Market Sales Analysis – Function | End-User | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Drug Discovery Informatics Market Sales Analysis – Function | End-User | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Drug Discovery Informatics Market Sales Analysis – Function | End-User | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Drug Discovery Informatics Market Sales Analysis – Function | End-User | Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Atomwise, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Benchling, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cadence Design Systems, Inc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Certara, L.P.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Charles River Laboratories International, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Chemaxon Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Clarivate plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Collaborative Drug Discovery, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Dassault Systèmes SE
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Dotmatics Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eurofins Scientific SE
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Evotec SE
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Exscientia Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Genedata AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Illumina, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Insilico Medicine, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Jubilant Biosys Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Revvity, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Schrödinger, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Atomwise, Inc.
1. Global Drug Discovery Informatics Market Research and Analysis by Function, 2025–2035 ($ Million)
2. Global Docking Drug Discovery Informatics Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Molecular Modeling Drug Discovery Informatics Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Libraries & Database Preparation Drug Discovery Informatics Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Sequencing & Target Data Analysis Drug Discovery Informatics Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Other Drug Discovery Informatics Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Drug Discovery Informatics Market Research and Analysis by End-User, 2025–2035 ($ Million)
8. Global Drug Discovery Informatics For Pharmaceutical & Biotechnology Companies Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Drug Discovery Informatics For Contract Research Organizations Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Drug Discovery Informatics For Others Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Drug Discovery Informatics Market Research and Analysis by Region, 2025–2035 ($ Million)
12. North American Drug Discovery Informatics Market Research and Analysis by Country, 2025–2035 ($ Million)
13. North American Drug Discovery Informatics Market Research and Analysis by Function, 2025–2035 ($ Million)
14. North American Drug Discovery Informatics Market Research and Analysis by End-User, 2025–2035 ($ Million)
15. European Drug Discovery Informatics Market Research and Analysis by Country, 2025–2035 ($ Million)
16. European Drug Discovery Informatics Market Research and Analysis by Function, 2025–2035 ($ Million)
17. European Drug Discovery Informatics Market Research and Analysis by End-User, 2025–2035 ($ Million)
18. Asia-Pacific Drug Discovery Informatics Market Research and Analysis by Country, 2025–2035 ($ Million)
19. Asia-Pacific Drug Discovery Informatics Market Research and Analysis by Function, 2025–2035 ($ Million)
20. Asia-Pacific Drug Discovery Informatics Market Research and Analysis by End-User, 2025–2035 ($ Million)
21. Rest of the World Drug Discovery Informatics Market Research and Analysis by Region, 2025–2035 ($ Million)
22. Rest of the World Drug Discovery Informatics Market Research and Analysis by Function, 2025–2035 ($ Million)
23. Rest of the World Drug Discovery Informatics Market Research and Analysis by End-User, 2025–2035 ($ Million)
1. Global Drug Discovery Informatics Market Share by Function, 2025 Vs 2035 (%)
2. Global Docking Drug Discovery Informatics Market Share by Region, 2025 Vs 2035 (%)
3. Global Molecular Modeling Drug Discovery Informatics Market Share by Region, 2025 Vs 2035 (%)
4. Global Libraries & Database Preparation Drug Discovery Informatics Market Share by Region, 2025 Vs 2035 (%)
5. Global Sequencing & Target Data Analysis Drug Discovery Informatics Market Share by Region, 2025 Vs 2035 (%)
6. Global Others Drug Discovery Informatics Type Market Share by Region, 2025 Vs 2035 (%)
7. Global Drug Discovery Informatics Market Share by End-User, 2025 Vs 2035 (%)
8. Global Drug Discovery Informatics For Pharmaceutical & Biotechnology Companies Market Share by Region, 2025 Vs 2035 (%)
9. Global Drug Discovery Informatics For Contract Research Organizations Market Share by Region, 2025 Vs 2035 (%)
10. Global Drug Discovery Informatics For Other Market Share by Region, 2025 Vs 2035 (%)
11. Global Drug Discovery Informatics Market Research and Analysis by Region, 2025–2035 ($ Million)
12. US Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
13. Canada Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
14. UK Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
15. France Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
16. Germany Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
17. Italy Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
18. Spain Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
19. Russia Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
20. Rest of Europe Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
21. India Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
22. China Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
23. Japan Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
24. South Korea Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
25. Australia and New Zealand Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
26. ASEAN Economies Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
27. Rest of Asia-Pacific Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
28. Latin America Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
29. Middle East and Africa Drug Discovery Informatics Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Drug Discovery Informatics Market in 2025 is estimated to be around $3,525.7 million.
North America holds the largest share in the Drug Discovery Informatics Market.
Leading players in the Drug Discovery Informatics Market include Dassault Systèmes SE, Clarivate plc, Illumina, Inc, Schrödinger, Inc, Thermo Fisher Scientific Inc., among others.
Drug Discovery Informatics Market is expected to grow at a CAGR of 8.2% from 2026 to 2035.
Rising adoption of AI and big data analytics, increasing drug R&D spending, need to reduce drug development time and cost, and growth of precision medicine are driving the Drug Discovery Informatics Market growth.
